Cellebrite DI Ltd.: history, ownership, mission, how it works & makes money

Cellebrite DI Ltd.: history, ownership, mission, how it works & makes money

IL | Technology | Software - Infrastructure | NASDAQ

Cellebrite DI Ltd. (CLBT) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Cellebrite DI Ltd., trading as CLBT on NASDAQ and quoted at $19.21 per share (latest trade 05:29:25 PST, intraday high $19.50 / low $19.31), has evolved from a 1999 Israeli startup into a global digital-intelligence vendor whose tools support roughly 7,000 customers and facilitate about 1.5 million investigations annually; after going public via a SPAC in August 2021 and completing strategic buys - including Corellium for enterprise value figures reported at around $170-200 million - the company is shifting to a recurring-revenue model with $408 million ARR in Q1 2025 and subscription revenue comprising 89% of total revenue (growing 21% YoY), while its UFED, Pathfinder and cloud offerings power investigations for law enforcement, defense and enterprise clients even as the firm navigates scrutiny over human-rights use of its tools and pursues growth into cybersecurity and defense markets.

Cellebrite DI Ltd. (CLBT): Intro

Cellebrite DI Ltd. is a publicly traded digital intelligence company (Nasdaq: CLBT) focused on extracting, decoding and analyzing data from mobile devices, cloud services and IoT sources for law enforcement, government, and enterprise customers. The company combines proprietary hardware, software and services to support investigations, intelligence, compliance and corporate security use cases.

Key real-time market snapshot:

Ticker Current Price (USD) Change Latest Open Intraday High Intraday Low Intraday Volume Latest Trade Time
CLBT 19.21 +0.52 (0.03%) 18.70 19.50 19.31 1,434 Monday, December 22, 05:29:25 PST

History and Evolution

  • Founded in Israel in 1999, initially focused on mobile forensics and data extraction from cell phones.
  • Expanded product portfolio over two decades to include cloud collection, analytics, automated triage, and enterprise security integrations.
  • Became publicly traded in the U.S. following a SPAC transaction and listing under the ticker CLBT (company history of public listing and corporate milestones has driven international expansion).

Ownership and Corporate Structure

  • Public company listed on the Nasdaq (CLBT), meaning ownership is distributed among institutional investors, retail shareholders and company insiders.
  • Major shareholders typically include mutual funds, hedge funds and strategic investors (exact ownership percentages fluctuate with filings).
  • Operates global regional offices and distributes through a mixture of direct sales, channel partners and government procurement contracts.

Mission and Strategic Focus

  • Mission: Enable lawful access to digital evidence and accelerate investigations by delivering comprehensive digital intelligence solutions.
  • Strategic focus areas: law enforcement modernization, enterprise security/insider threat detection, cloud and cross-platform data collection, AI-enabled analytics and automation.
  • Emphasis on product scalability, subscription-based revenue, training/certification services and compliance with legal/ethical standards.

How Cellebrite's Technology Works

Cellebrite's platform integrates hardware, software and cloud services to collect, decode and analyze digital data.

  • Data acquisition: Specialized forensic hardware and software extract data from mobile devices, SIMs, storage and IoT endpoints, using physical, logical and file system techniques.
  • Cloud and network collection: Connectors and legal-compliance workflows collect data from cloud services, social media and enterprise systems.
  • Decoding and normalization: Proprietary decoders parse file systems, app artifacts and proprietary formats into standardized, searchable datasets.
  • Analytics and reporting: AI-assisted analytics, timeline construction, link analysis and automated reporting tools accelerate investigations and evidence presentation.
  • Workflow and automation: Case management, role-based access and audit trails support chain-of-custody and judicial requirements.

Business and Revenue Model

  • Product sales: One-time hardware and perpetual-license components for forensic workstations and extraction devices.
  • Subscription and SaaS: Recurring revenue from cloud-based analytics, remote collection, back-end services and software updates.
  • Support and maintenance: Annual contracts for technical support, updates and decoder releases.
  • Training and professional services: Paid training courses, certification programs and high-touch investigative support and consulting.
  • Government contracts and enterprise deployments: Long-term procurement, renewals and multi-year frameworks driving predictable revenue streams.

Selected Financial and Operational Metrics (illustrative categories)

Metric Typical/Observed
Stock Ticker CLBT
Market Price (snapshot) 19.21 USD
Recent Intraday Volume 1,434 shares
Revenue Drivers Device sales, software subscriptions, maintenance, training & services, government contracts
Customer Base Law enforcement, public safety agencies, intelligence agencies, corporate security teams
Geographic Reach Global - Americas, EMEA, APAC

Competitive Positioning and Risks

  • Strengths: Specialized technical expertise, integrated hardware-software-cloud stack, entrenched law enforcement relationships, broad protocol/device support.
  • Risks: Regulatory and policy scrutiny regarding privacy and lawful access, rapid device encryption changes, competition from niche and open-source tools, dependence on government budgets.
  • Mitigants: Continuous R&D, decoder updates, compliance frameworks, diversification into enterprise and cloud-native offerings.

For further investor-focused context and shareholder composition analysis, see: Exploring Cellebrite DI Ltd. Investor Profile: Who's Buying and Why?

Cellebrite DI Ltd. (CLBT): History

Cellebrite DI Ltd. (CLBT) was founded in 1999 in Petah Tikva, Israel, by Avi Yablonka, Yaron Baratz, and Yuval Aflalo as a digital forensics firm focused on mobile-device data extraction and analysis. Over the following decades the company evolved from handset unlocking and forensic hardware to a broader platform offering cloud, AI-driven analytics, and enterprise security solutions.
  • 1999 - Founded in Petah Tikva, Israel.
  • August 2021 - Went public via SPAC merger; stock began trading on NASDAQ under ticker CLBT.
  • January 2024 - Launched 'Operation Find Them All,' donating AI investigative tools to nonprofits including the National Center for Missing & Exploited Children and The Exodus Road.
  • December 2024 - Amnesty International reported Serbian police used Cellebrite tools to bypass device security for journalists and activists; Cellebrite halted product use in Serbia in February 2025.
  • July 2024 - Acquired Cyber Technology Services, a U.S.-based cybersecurity firm licensed for federal projects.
  • June 2025 - Acquired Corellium (Florida) for $200 million (cash and stock).
Date Event Key Financial/Operational Detail
1999 Founding Established as mobile-device forensic specialist
Aug 2021 SPAC IPO Public listing on NASDAQ as CLBT (pro forma valuation at time of merger: multi‑hundreds of millions to low billions)
Jan 2024 Operation Find Them All Donated AI-driven investigative tools to child-protection NGOs
Jul 2024 Acquisition: Cyber Technology Services Expanded U.S. federal-licensed cybersecurity capabilities
Dec 2024-Feb 2025 Serbia controversy & suspension Amnesty report led to suspension of product use in Serbia
Jun 2025 Acquisition: Corellium Purchase price $200,000,000 (cash + stock)
  • Ownership & structure: Publicly traded as Cellebrite DI Ltd. (CLBT) on NASDAQ following the 2021 SPAC merger; ownership mix includes institutional investors, company insiders, and public shareholders.
  • Core capabilities: mobile-device extraction, cloud data acquisition, AI-driven analytics, virtualization and emulation (bolstered by Corellium), and federal‑compliant cybersecurity services (bolstered by Cyber Technology Services).
Mission Statement, Vision, & Core Values (2026) of Cellebrite DI Ltd.

Cellebrite DI Ltd. (CLBT): Ownership Structure

  • Public listing: As of late 2025, Cellebrite DI Ltd. is publicly traded on NASDAQ under ticker CLBT.
  • Largest shareholder: Sun Corporation (Nagoya, Japan) holds a 44% stake in Cellebrite.
  • Free float: Remaining 56% is publicly held (institutions, mutual funds, ETFs, and retail investors).
Holder Stake Notes
Sun Corporation 44% Strategic anchor investor; largest single shareholder
Public float (institutions & retail) 56% Traded on NASDAQ as CLBT
  • Board and governance:
    • Thomas E. Hogan - Interim CEO
    • Adam H. Clammer - Board Chairman
    • Michael D. Capellas - Lead Independent Director
  • Finance leadership: In July 2025, David Barter joined as CFO, adding technology and software finance expertise.
Event Date Financial Terms Strategic Impact
Acquisition of Corellium December 2025 Enterprise value $170 million ( $150M cash + $20M equity ) Expands addressable market into defense & intelligence; strengthens device and virtualization toolset
  • How ownership shapes strategy:
    • Sun Corporation's 44% stake provides a stable strategic anchor for long-term investments and M&A financing.
    • Public ownership (56%) demands quarterly performance transparency and liquidity for shareholders.
    • The Corellium acquisition, funded partly by equity, signals use of balance-sheet flexibility to broaden market reach.
Cellebrite DI Ltd.: History, Ownership, Mission, How It Works & Makes Money

Cellebrite DI Ltd. (CLBT): Mission and Values

Cellebrite DI Ltd. (CLBT) positions itself as a leader in digital intelligence and forensics, focused on accelerating investigations and enhancing public safety by providing tools for data extraction, decoding, analysis and case management across mobile devices, cloud services, drones and IoT endpoints. The company has emphasized continuous innovation-particularly AI-driven analytics and automation-to modernize investigations for law enforcement, intelligence, military and enterprise customers worldwide. Public-market milestones include a U.S. listing via a SPAC transaction in 2021 (ticker: CLBT), enabling broader access to growth capital and accelerating R&D and global go-to-market expansion.
  • Primary mission: enable faster, more accurate digital investigations through advanced extraction, decoding, analysis and triage capabilities.
  • Core focus areas: law enforcement, national security, corporate investigations, and child protection NGOs.
  • Ethical stance: promote lawful, accountable use of digital intelligence tools with human-rights and privacy considerations built into policies and partner agreements.
Operational and social commitments are reflected in programs that provide donated investigative tooling and training to nonprofits focused on locating missing and exploited children and supporting victim identification workflows. Cellebrite states these donations are targeted at organizations engaged in frontline rescue and victim recovery efforts (partners historically include child-protection NGOs and law-enforcement support groups).
  • Collaboration: works closely with government agencies, OEMs, academic institutions and NGOs to validate methods and share best practices.
  • Social responsibility: donates AI-driven investigative tools and training to nonprofits addressing child exploitation and missing-persons cases.
  • R&D-driven innovation: invests significant resources into AI/ML, cloud-enabled analytics and automation to reduce investigator time-to-evidence.
Metric / Area Representative Figure or Example
Public listing SPAC-backed U.S. listing in 2021 (ticker CLBT)
Employees (approx.) ~1,500-1,700 globally (engineering, field, legal/compliance, support)
Revenue growth profile Consistent double-digit annual growth in recent years; focus on growing subscriptions and services
R&D intensity Material share of revenue reinvested into R&D (company-reported priority area; typical peer range 15-25% of revenue)
Customer base Thousands of agencies and enterprises worldwide across public safety, intelligence and corporate security
Key value statements and how they translate into products and policy:
  • Innovation: continuous software updates, AI-based analytics modules, and cloud-native capabilities that shorten investigative timelines and increase evidence yield.
  • Reliability & validation: regularly published tool capability matrices, partner certifications and lab-tested forensic methods to ensure reproducibility and legal defensibility.
  • Responsible use: contractual safeguards, export-control compliance, and end-user agreements intended to limit misuse and align deployments with legal frameworks.
Examples of mission-to-product mapping (high-level):
  • Extraction & decoding - enabling access to device and cloud data at scale for investigators.
  • Analysis & triage - AI-driven prioritization and multimedia tagging to reduce manual review hours.
  • Case management & evidence export - structured workflows and court-ready reporting to preserve chain-of-custody.
For further articulation of Cellebrite's stated mission, vision and values, see: Mission Statement, Vision, & Core Values (2026) of Cellebrite DI Ltd.

Cellebrite DI Ltd. (CLBT): How It Works

Cellebrite DI Ltd. (CLBT) provides a vertically integrated suite of digital forensics, data-extraction, analytics and cloud solutions used by law enforcement, government agencies, corporations and service providers to access, process and interpret digital evidence from mobile devices, cloud services and social media platforms. Its core technologies combine hardware extraction tools, proprietary decoding software, AI-driven analytics and cloud orchestration to accelerate investigations and produce court-defensible outputs.
  • Flagship extraction: The Universal Forensic Extraction Device (UFED) performs logical, file system and physical extractions across iOS, Android and feature phones using direct cable, chip-off or bootloader techniques and supports thousands of app artefacts and file formats.
  • Decoding & parsing: Proprietary decoders translate raw dumps into human-readable artifacts (messages, call logs, file metadata, app-specific data) and map proprietary app containers into standardized evidentiary formats.
  • AI & analytics: Pathfinder and related AI modules ingest vast, often encrypted datasets to prioritize leads, cluster contacts and surface timelines - reducing manual review time substantially in large caseloads.
  • Cloud integration: Cellebrite Cloud aggregates synchronized backups, social media and third-party cloud data for expedited access without relying solely on physical device acquisitions.
  • End-to-end workflow: Tools support triage and onsite first-responder use (mobile field kits), lab-grade forensic examiners, analysts, investigators and prosecutors with chain-of-custody logs and report generation to support admissibility.
  • Data presentation: Built-in visualization, timeline building and export to standard forensic reports enhance courtroom and investigative communications.
Component Function Primary Use Case Delivery / Licensing
UFED (hardware + software) Device acquisition (logical/physical) On-device evidence recovery Perpetual / subscription for software updates
Physical Extraction Kit (chip-off) Bypass damaged devices / raw memory reads Advanced lab recoveries Sold as hardware consumable + service
Pathfinder (AI) Entity linking, clustering, timeline creation Lead prioritization in large datasets Cloud/subscription
Cellebrite Cloud Cloud data collection, indexing, case management Remote acquisition of backups and cloud-native evidence Subscription (SaaS)
Analytics & Reporting Visualization, search, export to court-ready formats Forensic analysis & prosecution packages Included with enterprise suites / add-on modules
Operational flow (typical):
  • Evidence intake: Triage or field extraction with UFED for rapid indicators (hashes, contacts, messages).
  • Deep extraction: Lab-based physical/chip methods for encrypted or damaged devices.
  • Ingestion: Data is parsed, decoded and indexed into the Cellebrite case management environment (on-prem or cloud).
  • AI processing: Pathfinder and analytics run to surface high-value leads, visualize networks and create timelines.
  • Production: Standardized, auditable reports, media exports and demonstrative visualizations for investigators and courts.
Key metrics & scale (recent, approximate):
  • Global customers: >15,000 agencies and enterprises (law enforcement, public safety, corporate security).
  • Installed base: Tens of thousands of UFED licenses and field kits distributed globally.
  • Employees: ~1,700-2,000 worldwide across R&D, legal, sales and support.
  • Revenue run-rate: Company-reported annual revenue in the low-to-mid hundreds of millions USD (growth driven by SaaS, analytics and enterprise subscriptions).
  • R&D intensity: Significant share of revenue reinvested into decoder updates, OS/app support and AI capabilities to maintain device/app parity.
Monetization & business model elements embedded in product design:
  • Hardware sales: UFED devices, physical extraction kits and field-ready appliances sold upfront.
  • Software & decoder subscriptions: Recurring fees for OS/app decoder updates, security patches and new device support.
  • SaaS / Cloud subscriptions: Cellebrite Cloud and Pathfinder subscriptions for continuous, multi-user, cloud-native workflows.
  • Support & training: Professional services, certifications, training contracts and prioritized support tiers.
  • Enterprise licensing: Large-agency and cross-border licensing with multi-year contracts, maintenance renewals and deployment services.
  • Consumables & forensic services: Chip-off consumables, lab services and third-party vendor partnerships for edge cases.
How Cellebrite's tooling improves investigation efficiency (quantified examples):
  • Case prioritization: AI-driven lead surfacing can reduce manual review volume by multiples (often cited reductions of 60-80% in tasking time for large datasets).
  • Throughput: Cloud orchestration and parallel parsing accelerate case cycle times; organizations report day-to-week processing versus multi-week backlogs for comparable caseloads.
  • Evidence yield: Physical extractions and targeted cloud pulls increase recoverable artefacts compared to logical-only approaches, improving case solvability rates in complex investigations.
Interoperability & compliance:
  • Support for major OS versions and thousands of app artefacts with continuous decoder updates to keep pace with encrypted messaging, ephemeral apps and vendor changes.
  • Chain-of-custody, audit logs and report templates designed to meet evidentiary standards across jurisdictions.
  • Privacy & legal controls: Case-level access management and redaction/export controls for sensitive data handling.
Mission Statement, Vision, & Core Values (2026) of Cellebrite DI Ltd.

Cellebrite DI Ltd. (CLBT): How It Makes Money

Cellebrite monetizes digital-forensics tools and services across government and enterprise markets, shifting from one-time device sales toward predictable, recurring revenue.
  • Primary products: hardware extractors, forensic software suites, analytics and case management tools sold to law enforcement, military, intelligence, and enterprise customers.
  • Subscription model: subscription revenue comprised 89% of total revenue in Q1 2025, with subscription revenue growth of 21% year-over-year in that quarter.
  • Annual recurring revenue (ARR): ARR reached $408 million in Q1 2025, a 23% increase year-over-year, signaling a move to more predictable cash flow.
  • Cloud & SaaS: cloud-based and SaaS offerings account for 20% of total ARR and grew over 50% year-over-year in the latest reported period.
  • Services & support: professional services - training, support, consulting - provide supplemental recurring and one-time revenue while deepening customer relationships.
  • M&A expansion: the acquisition of Corellium is expected to broaden Cellebrite's addressable market, particularly in defense and intelligence, and create new revenue streams tied to advanced device emulation and mobile-security tooling.
Metric Value YoY Change
Subscription share of revenue (Q1 2025) 89% +21% subscription revenue YoY (Q1 2025)
Annual Recurring Revenue (ARR) $408 million +23% YoY (Q1 2025)
Cloud & SaaS share of ARR 20% >50% YoY growth
Target customers Law enforcement, military, intelligence, enterprise -
Ancillary revenue Training, support, consulting Contributes recurring + one-time fees
Exploring Cellebrite DI Ltd. Investor Profile: Who's Buying and Why?

DCF model

Cellebrite DI Ltd. (CLBT) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.